ATC code none CAS Number 508233-95-2 KEGG D10170 Pubchem 9878913 | Legal status Investigational PubChem CID 9878913 Molar mass 283.43 g/mol ChemSpider ID 8054590 | |
 | ||
Synonyms Lu AA24530; Lu-AA-24530 | ||
How to pronounce tedatioxetine
Tedatioxetine (Lu AA24530) is an antidepressant that was discovered by scientists at Lundbeck; in 2007 Lundbeck and Takeda entered into a partnership that included tedatioxetine but was focused on another, more advanced Lundbeck drug candidate, vortioxetine.
Tedatioxetine is reported to act as a triple reuptake inhibitor (5-HT > NE > DA) and 5-HT2A, 5-HT2C, 5-HT3 and α1A-adrenergic receptor antagonist.
As of 2009, it was in phase II clinical trials for major depressive disorder, but there have been no updates since then, and as of August 2013 it was no longer displayed on Lundbeck's product pipeline.
On May 10, 2016, all work on tedatioxetine stopped.
References
Tedatioxetine Wikipedia(Text) CC BY-SA